Privia Health (PRVA) Cash & Equivalents (2020 - 2026)

Privia Health's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $419.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 10.61% year-over-year to $419.5 million; the TTM figure through Mar 2026 stood at $419.5 million (down 10.61% YoY), while the FY2025 annual figure was $479.7 million, down 2.33% from the prior year.
• Cash & Equivalents was $419.5 million for Q1 2026 at Privia Health, down from $479.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $491.1 million in Q4 2024 to a low of $292.2 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $380.8 million across 5 years, with a median of $387.4 million in 2024.
• Biggest YoY gain for Cash & Equivalents was 285.57% in 2022; the steepest drop was 12.49% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $348.0 million in 2022, then grew by 11.93% to $389.5 million in 2023, then grew by 26.09% to $491.1 million in 2024, then slipped by 2.33% to $479.7 million in 2025, then dropped by 12.54% to $419.5 million in 2026.
• The last three Cash & Equivalents figures came in at $419.5 million (Q1 2026), $479.7 million (Q4 2025), and $441.4 million (Q3 2025), per Business Quant data.